APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Mesalamine

Mesalamine, also known as Mesalamine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Mesalamine, also known as Mesalamine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.

Selected research

Market Outlook & Growth Opportunities

Global Mesalamine Market Outlook and Growth Opportunities 2026

Report ID 174012290427 December 2025194 pages

Choose your research edition.

Industry ResearchMesalamine Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Mesalamine Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Mesalamine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mesalamine Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Mesalamine Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

Mesalamine, also known as Mesalamine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.

The industry's leading manufacturers are Syntese A/S, Divis Laboratories, ipca Laboratories and Cambrex Corporation, which accounted for 23.74%, 14.71%, 6.44% and 6.35% of the global revenue share in 2019, respectively.

In terms of regions, the revenue share of Europe is the highest, reaching 41.11% in 2019.

Read the full market overview

This report provides an overview of the global Mesalamine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Mesalamine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Mesalamine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Mesalamine market size, projected growth trends, production technologies, key applications, and end-use industries.

Mesalamine Segment by Company

Syntese A/S

Divis Laboratories

Cambrex Corporation

Ipca Laboratories

Hangzhou Brother

PharmaZell

Lianyungang Fengheng Biopharm

Lasa Loboratory

Erregierre SpA

Corden Pharma Bergamo

CTX Lifescience

Ishita Active Pharma Ingredients

YC Biotech (Jiangsu)

Xinxiang Tianfeng Fine Chemical

Mesalamine Segment by Type

Purity ≥ 97%

Purity ≥ 98%

Purity ≥ 99%

Mesalamine Segment by Application

Mesalazine Tablets

Mesalazine Capsules

Others

Mesalamine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Mesalamine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Mesalamine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Mesalamine significant trends, drivers, influence factors in global and regions.

6. To analyze Mesalamine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mesalamine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mesalamine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mesalamine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Mesalamine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Mesalamine industry.

Chapter 3: Detailed analysis of Mesalamine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Mesalamine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Mesalamine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Mesalamine Industry Trends Table 2. Mesalamine Industry Drivers Table 3. Mesalamine Industry Opportunities and Challenges Table 4. Mesalamine Industry Restraints Table 5. Global Mesalamine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Mesalamine Revenue Share by Company (2021-2026) Table 7. Global Mesalamine Sales Volume by Company (MT) & (2021-2026) Table 8. Global Mesalamine Sales Volume Share by Company (2021-2026) Table 9. Global Mesalamine Average Price (USD/Kg) of Company (2021-2026) Table 10. Global Mesalamine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Mesalamine Key Company Manufacturing Base & Headquarters Table 12. Global Mesalamine Company, Product Type & Application Table 13. Global Mesalamine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Mesalamine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Purity ≥ 97% Table 18. Significant Companies of Purity ≥ 98% Table 19. Significant Companies of Purity ≥ 99% Table 20. Global Mesalamine Sales Volume by Type 2021 VS 2025 VS 2032 (MT) Table 21. Global Mesalamine Sales Volume by Type (2021-2026) & (MT) Table 22. Global Mesalamine Sales Volume by Type (2027-2032) & (MT) Table 23. Global Mesalamine Sales Volume Share by Type (2021-2026) Table 24. Global Mesalamine Sales Volume Share by Type (2027-2032) Table 25. Global Mesalamine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Mesalamine Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Mesalamine Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Mesalamine Sales Value Share by Type (2021-2026) Table 29. Global Mesalamine Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Mesalazine Tablets Table 31. Significant Companies of Mesalazine Capsules Table 32. Significant Companies of Others Table 33. Global Mesalamine Sales Volume by Application 2021 VS 2025 VS 2032 (MT) Table 34. Global Mesalamine Sales Volume by Application (2021-2026) & (MT) Table 35. Global Mesalamine Sales Volume by Application (2027-2032) & (MT) Table 36. Global Mesalamine Sales Volume Share by Application (2021-2026) Table 37. Global Mesalamine Sales Volume Share by Application (2027-2032) Table 38. Global Mesalamine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Mesalamine Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Mesalamine Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Mesalamine Sales Value Share by Application (2021-2026) Table 42. Global Mesalamine Sales Value Share by Application (2027-2032) Table 43. Global Mesalamine Sales by Region: 2021 VS 2025 VS 2032 (MT) Table 44. Global Mesalamine Sales by Region (2021-2026) & (MT) Table 45. Global Mesalamine Sales Market Share by Region (2021-2026) Table 46. Global Mesalamine Sales by Region (2027-2032) & (MT) Table 47. Global Mesalamine Sales Market Share by Region (2027-2032) Table 48. Global Mesalamine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Mesalamine Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Mesalamine Sales Value Share by Region (2021-2026) Table 51. Global Mesalamine Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Mesalamine Sales Value Share by Region (2027-2032) Table 53. Global Mesalamine Market Average Price (USD/Kg) by Region (2021-2026) Table 54. Global Mesalamine Market Average Price (USD/Kg) by Region (2027-2032) Table 55. Global Mesalamine Sales by Country: 2021 VS 2025 VS 2032 (MT) Table 56. Global Mesalamine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Mesalamine Sales by Country (2021-2026) & (MT) Table 58. Global Mesalamine Sales Market Share by Country (2021-2026) Table 59. Global Mesalamine Sales by Country (2027-2032) & (MT) Table 60. Global Mesalamine Sales Market Share by Country (2027-2032) Table 61. Global Mesalamine Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Mesalamine Sales Value Market Share by Country (2021-2026) Table 63. Global Mesalamine Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Mesalamine Sales Value Market Share by Country (2027-2032) Table 65. Syntese A/S Company Information Table 66. Syntese A/S Business Overview Table 67. Syntese A/S Mesalamine Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 68. Syntese A/S Mesalamine Product Portfolio Table 69. Syntese A/S Recent Development Table 70. Divis Laboratories Company Information Table 71. Divis Laboratories Business Overview Table 72. Divis Laboratories Mesalamine Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 73. Divis Laboratories Mesalamine Product Portfolio Table 74. Divis Laboratories Recent Development Table 75. Cambrex Corporation Company Information Table 76. Cambrex Corporation Business Overview Table 77. Cambrex Corporation Mesalamine Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 78. Cambrex Corporation Mesalamine Product Portfolio Table 79. Cambrex Corporation Recent Development Table 80. Ipca Laboratories Company Information Table 81. Ipca Laboratories Business Overview Table 82. Ipca Laboratories Mesalamine Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 83. Ipca Laboratories Mesalamine Product Portfolio Table 84. Ipca Laboratories Recent Development Table 85. Hangzhou Brother Company Information Table 86. Hangzhou Brother Business Overview Table 87. Hangzhou Brother Mesalamine Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 88. Hangzhou Brother Mesalamine Product Portfolio Table 89. Hangzhou Brother Recent Development Table 90. PharmaZell Company Information Table 91. PharmaZell Business Overview Table 92. PharmaZell Mesalamine Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 93. PharmaZell Mesalamine Product Portfolio Table 94. PharmaZell Recent Development Table 95. Lianyungang Fengheng Biopharm Company Information Table 96. Lianyungang Fengheng Biopharm Business Overview Table 97. Lianyungang Fengheng Biopharm Mesalamine Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 98. Lianyungang Fengheng Biopharm Mesalamine Product Portfolio Table 99. Lianyungang Fengheng Biopharm Recent Development Table 100. Lasa Loboratory Company Information Table 101. Lasa Loboratory Business Overview Table 102. Lasa Loboratory Mesalamine Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 103. Lasa Loboratory Mesalamine Product Portfolio Table 104. Lasa Loboratory Recent Development Table 105. Erregierre SpA Company Information Table 106. Erregierre SpA Business Overview Table 107. Erregierre SpA Mesalamine Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 108. Erregierre SpA Mesalamine Product Portfolio Table 109. Erregierre SpA Recent Development Table 110. Corden Pharma Bergamo Company Information Table 111. Corden Pharma Bergamo Business Overview Table 112. Corden Pharma Bergamo Mesalamine Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 113. Corden Pharma Bergamo Mesalamine Product Portfolio Table 114. Corden Pharma Bergamo Recent Development Table 115. CTX Lifescience Company Information Table 116. CTX Lifescience Business Overview Table 117. CTX Lifescience Mesalamine Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 118. CTX Lifescience Mesalamine Product Portfolio Table 119. CTX Lifescience Recent Development Table 120. Ishita Active Pharma Ingredients Company Information Table 121. Ishita Active Pharma Ingredients Business Overview Table 122. Ishita Active Pharma Ingredients Mesalamine Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 123. Ishita Active Pharma Ingredients Mesalamine Product Portfolio Table 124. Ishita Active Pharma Ingredients Recent Development Table 125. YC Biotech (Jiangsu) Company Information Table 126. YC Biotech (Jiangsu) Business Overview Table 127. YC Biotech (Jiangsu) Mesalamine Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 128. YC Biotech (Jiangsu) Mesalamine Product Portfolio Table 129. YC Biotech (Jiangsu) Recent Development Table 130. Xinxiang Tianfeng Fine Chemical Company Information Table 131. Xinxiang Tianfeng Fine Chemical Business Overview Table 132. Xinxiang Tianfeng Fine Chemical Mesalamine Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 133. Xinxiang Tianfeng Fine Chemical Mesalamine Product Portfolio Table 134. Xinxiang Tianfeng Fine Chemical Recent Development Table 135. Key Raw Materials Table 136. Raw Materials Key Suppliers Table 137. Mesalamine Distributors List Table 138. Mesalamine Customers List Table 139. Research Programs/Design for This Report Table 140. Authors List of This Report Table 141. Secondary Sources Table 142. Primary Sources List of Figures Figure 1. Mesalamine Product Image Figure 2. Global Mesalamine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Mesalamine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Mesalamine Sales (2021-2032) & (MT) Figure 5. Global Mesalamine Sales Average Price (USD/Kg) & (2021-2032) Figure 6. Global Mesalamine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Purity ≥ 97% Image Figure 10. Purity ≥ 98% Image Figure 11. Purity ≥ 99% Image Figure 12. Global Mesalamine Sales Volume by Type (2021 VS 2025 VS 2032) & (MT) Figure 13. Global Mesalamine Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Mesalamine Sales Volume Share by Type (2021-2032) Figure 15. Global Mesalamine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Mesalamine Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Mesalamine Sales Value Share by Type (2021-2032) Figure 18. Mesalazine Tablets Image Figure 19. Mesalazine Capsules Image Figure 20. Others Image Figure 21. Global Mesalamine Sales Volume by Application (2021 VS 2025 VS 2032) & (MT) Figure 22. Global Mesalamine Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Mesalamine Sales Volume Share by Application (2021-2032) Figure 24. Global Mesalamine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Mesalamine Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Mesalamine Sales Value Share by Application (2021-2032) Figure 27. Global Mesalamine Sales by Region: 2021 VS 2025 VS 2032 (MT) Figure 28. Global Mesalamine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Mesalamine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Mesalamine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Mesalamine Sales Value (2021-2032) & (US$ Million) Figure 32. North America Mesalamine Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Mesalamine Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Mesalamine Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Mesalamine Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Mesalamine Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Mesalamine Sales Value (2021-2032) & (US$ Million) Figure 38. South America Mesalamine Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Mesalamine Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Mesalamine Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Mesalamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Mesalamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Mesalamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Mesalamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Mesalamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Mesalamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Mesalamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Mesalamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Mesalamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Mesalamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Mesalamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Mesalamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Mesalamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Mesalamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Mesalamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Mesalamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Mesalamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Mesalamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Mesalamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Mesalamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Mesalamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Mesalamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Mesalamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Mesalamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Mesalamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Mesalamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Mesalamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Mesalamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Mesalamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Mesalamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Mesalamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Mesalamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Mesalamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Mesalamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Mesalamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Mesalamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Mesalamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Mesalamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Mesalamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Mesalamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Mesalamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Mesalamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Mesalamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Mesalamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Mesalamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Mesalamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Mesalamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Mesalamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Mesalamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Mesalamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Mesalamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Mesalamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Mesalamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Mesalamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Mesalamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Mesalamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Mesalamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Mesalamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Mesalamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Mesalamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Mesalamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Mesalamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Mesalamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Mesalamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Mesalamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Mesalamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Mesalamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Mesalamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Mesalamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Mesalamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Mesalamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Mesalamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Mesalamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Mesalamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Mesalamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Mesalamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Mesalamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Mesalamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Mesalamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Mesalamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Mesalamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Mesalamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Mesalamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Mesalamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Mesalamine Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Mesalamine Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Purity ≥ 97%
  • Purity ≥ 98%
  • Purity ≥ 99%
Applications
  • Mesalazine Tablets
  • Mesalazine Capsules
  • Others
Companies covered
  • Syntese A/S
  • Divis Laboratories
  • Cambrex Corporation
  • Ipca Laboratories
  • Hangzhou Brother
  • PharmaZell
  • Lianyungang Fengheng Biopharm
  • Lasa Loboratory
  • Erregierre SpA
  • Corden Pharma Bergamo
  • CTX Lifescience
  • Ishita Active Pharma Ingredients
  • YC Biotech (Jiangsu)
  • Xinxiang Tianfeng Fine Chemical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Mesalamine Sales Value (2021-2032)
  4. 1.2.2 Global Mesalamine Sales Volume (2021-2032)
  5. 1.2.3 Global Mesalamine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Mesalamine Market Dynamics
  1. 2.1 Mesalamine Industry Trends
  2. 2.2 Mesalamine Industry Drivers
  3. 2.3 Mesalamine Industry Opportunities and Challenges
  4. 2.4 Mesalamine Industry Restraints
3 Mesalamine Market by Company
  1. 3.1 Global Mesalamine Company Revenue Ranking in 2025
  2. 3.2 Global Mesalamine Revenue by Company (2021-2026)
  3. 3.3 Global Mesalamine Sales Volume by Company (2021-2026)
  4. 3.4 Global Mesalamine Average Price by Company (2021-2026)
  5. 3.5 Global Mesalamine Company Ranking (2024-2026)
  6. 3.6 Global Mesalamine Company Manufacturing Base and Headquarters
  7. 3.7 Global Mesalamine Company Product Type and Application
  8. 3.8 Global Mesalamine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Mesalamine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Mesalamine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Mesalamine Market by Type
  1. 4.1 Mesalamine Type Introduction
  2. 4.1.1 Purity ≥ 97%
  3. 4.1.2 Purity ≥ 98%
  4. 4.1.3 Purity ≥ 99%
  5. 4.2 Global Mesalamine Sales Volume by Type
  6. 4.2.1 Global Mesalamine Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Mesalamine Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Mesalamine Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Mesalamine Sales Value by Type
  10. 4.3.1 Global Mesalamine Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Mesalamine Sales Value by Type (2021-2032)
  12. 4.3.3 Global Mesalamine Sales Value Share by Type (2021-2032)
5 Mesalamine Market by Application
  1. 5.1 Mesalamine Application Introduction
  2. 5.1.1 Mesalazine Tablets
  3. 5.1.2 Mesalazine Capsules
  4. 5.1.3 Others
  5. 5.2 Global Mesalamine Sales Volume by Application
  6. 5.2.1 Global Mesalamine Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Mesalamine Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Mesalamine Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Mesalamine Sales Value by Application
  10. 5.3.1 Global Mesalamine Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Mesalamine Sales Value by Application (2021-2032)
  12. 5.3.3 Global Mesalamine Sales Value Share by Application (2021-2032)
6 Mesalamine Regional Sales and Value Analysis
  1. 6.1 Global Mesalamine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Mesalamine Sales by Region (2021-2032)
  3. 6.2.1 Global Mesalamine Sales by Region: 2021-2026
  4. 6.2.2 Global Mesalamine Sales by Region (2027-2032)
  5. 6.3 Global Mesalamine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Mesalamine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Mesalamine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Mesalamine Sales Value by Region (2027-2032)
  9. 6.5 Global Mesalamine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Mesalamine Sales Value (2021-2032)
  12. 6.6.2 North America Mesalamine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Mesalamine Sales Value (2021-2032)
  15. 6.7.2 Europe Mesalamine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Mesalamine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Mesalamine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Mesalamine Sales Value (2021-2032)
  21. 6.9.2 South America Mesalamine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Mesalamine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Mesalamine Sales Value Share by Country, 2025 VS 2032
7 Mesalamine Country-level Sales and Value Analysis
  1. 7.1 Global Mesalamine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Mesalamine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Mesalamine Sales by Country (2021-2032)
  4. 7.3.1 Global Mesalamine Sales by Country (2021-2026)
  5. 7.3.2 Global Mesalamine Sales by Country (2027-2032)
  6. 7.4 Global Mesalamine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Mesalamine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Mesalamine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Mesalamine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Mesalamine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Mesalamine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Mesalamine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Mesalamine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Mesalamine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Mesalamine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Mesalamine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Mesalamine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Mesalamine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Mesalamine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Mesalamine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Mesalamine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Mesalamine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Mesalamine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Mesalamine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Mesalamine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Mesalamine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Mesalamine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Mesalamine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Mesalamine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Mesalamine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Mesalamine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Mesalamine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Mesalamine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Mesalamine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Mesalamine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Mesalamine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Mesalamine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Mesalamine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Mesalamine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Mesalamine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Mesalamine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Mesalamine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Mesalamine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Mesalamine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Mesalamine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Mesalamine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Mesalamine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Mesalamine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Mesalamine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Mesalamine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Mesalamine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Mesalamine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Mesalamine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Mesalamine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Mesalamine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Mesalamine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Mesalamine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Mesalamine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Mesalamine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Mesalamine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Mesalamine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Mesalamine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Mesalamine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Mesalamine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Mesalamine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Mesalamine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Mesalamine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Mesalamine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Mesalamine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Mesalamine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Mesalamine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Mesalamine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Mesalamine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Mesalamine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Mesalamine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Mesalamine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Mesalamine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Mesalamine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Mesalamine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Mesalamine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Mesalamine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Mesalamine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Mesalamine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Mesalamine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Mesalamine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Mesalamine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Mesalamine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Mesalamine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Mesalamine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Mesalamine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Mesalamine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Mesalamine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Syntese A/S
  2. 8.1.1 Syntese A/S Company Information
  3. 8.1.2 Syntese A/S Business Overview
  4. 8.1.3 Syntese A/S Mesalamine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Syntese A/S Mesalamine Product Portfolio
  6. 8.1.5 Syntese A/S Recent Developments
  7. 8.2 Divis Laboratories
  8. 8.2.1 Divis Laboratories Company Information
  9. 8.2.2 Divis Laboratories Business Overview
  10. 8.2.3 Divis Laboratories Mesalamine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Divis Laboratories Mesalamine Product Portfolio
  12. 8.2.5 Divis Laboratories Recent Developments
  13. 8.3 Cambrex Corporation
  14. 8.3.1 Cambrex Corporation Company Information
  15. 8.3.2 Cambrex Corporation Business Overview
  16. 8.3.3 Cambrex Corporation Mesalamine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Cambrex Corporation Mesalamine Product Portfolio
  18. 8.3.5 Cambrex Corporation Recent Developments
  19. 8.4 Ipca Laboratories
  20. 8.4.1 Ipca Laboratories Company Information
  21. 8.4.2 Ipca Laboratories Business Overview
  22. 8.4.3 Ipca Laboratories Mesalamine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Ipca Laboratories Mesalamine Product Portfolio
  24. 8.4.5 Ipca Laboratories Recent Developments
  25. 8.5 Hangzhou Brother
  26. 8.5.1 Hangzhou Brother Company Information
  27. 8.5.2 Hangzhou Brother Business Overview
  28. 8.5.3 Hangzhou Brother Mesalamine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Hangzhou Brother Mesalamine Product Portfolio
  30. 8.5.5 Hangzhou Brother Recent Developments
  31. 8.6 PharmaZell
  32. 8.6.1 PharmaZell Company Information
  33. 8.6.2 PharmaZell Business Overview
  34. 8.6.3 PharmaZell Mesalamine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 PharmaZell Mesalamine Product Portfolio
  36. 8.6.5 PharmaZell Recent Developments
  37. 8.7 Lianyungang Fengheng Biopharm
  38. 8.7.1 Lianyungang Fengheng Biopharm Company Information
  39. 8.7.2 Lianyungang Fengheng Biopharm Business Overview
  40. 8.7.3 Lianyungang Fengheng Biopharm Mesalamine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Lianyungang Fengheng Biopharm Mesalamine Product Portfolio
  42. 8.7.5 Lianyungang Fengheng Biopharm Recent Developments
  43. 8.8 Lasa Loboratory
  44. 8.8.1 Lasa Loboratory Company Information
  45. 8.8.2 Lasa Loboratory Business Overview
  46. 8.8.3 Lasa Loboratory Mesalamine Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Lasa Loboratory Mesalamine Product Portfolio
  48. 8.8.5 Lasa Loboratory Recent Developments
  49. 8.9 Erregierre SpA
  50. 8.9.1 Erregierre SpA Company Information
  51. 8.9.2 Erregierre SpA Business Overview
  52. 8.9.3 Erregierre SpA Mesalamine Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Erregierre SpA Mesalamine Product Portfolio
  54. 8.9.5 Erregierre SpA Recent Developments
  55. 8.10 Corden Pharma Bergamo
  56. 8.10.1 Corden Pharma Bergamo Company Information
  57. 8.10.2 Corden Pharma Bergamo Business Overview
  58. 8.10.3 Corden Pharma Bergamo Mesalamine Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Corden Pharma Bergamo Mesalamine Product Portfolio
  60. 8.10.5 Corden Pharma Bergamo Recent Developments
  61. 8.11 CTX Lifescience
  62. 8.11.1 CTX Lifescience Company Information
  63. 8.11.2 CTX Lifescience Business Overview
  64. 8.11.3 CTX Lifescience Mesalamine Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 CTX Lifescience Mesalamine Product Portfolio
  66. 8.11.5 CTX Lifescience Recent Developments
  67. 8.12 Ishita Active Pharma Ingredients
  68. 8.12.1 Ishita Active Pharma Ingredients Company Information
  69. 8.12.2 Ishita Active Pharma Ingredients Business Overview
  70. 8.12.3 Ishita Active Pharma Ingredients Mesalamine Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Ishita Active Pharma Ingredients Mesalamine Product Portfolio
  72. 8.12.5 Ishita Active Pharma Ingredients Recent Developments
  73. 8.13 YC Biotech (Jiangsu)
  74. 8.13.1 YC Biotech (Jiangsu) Company Information
  75. 8.13.2 YC Biotech (Jiangsu) Business Overview
  76. 8.13.3 YC Biotech (Jiangsu) Mesalamine Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 YC Biotech (Jiangsu) Mesalamine Product Portfolio
  78. 8.13.5 YC Biotech (Jiangsu) Recent Developments
  79. 8.14 Xinxiang Tianfeng Fine Chemical
  80. 8.14.1 Xinxiang Tianfeng Fine Chemical Company Information
  81. 8.14.2 Xinxiang Tianfeng Fine Chemical Business Overview
  82. 8.14.3 Xinxiang Tianfeng Fine Chemical Mesalamine Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Xinxiang Tianfeng Fine Chemical Mesalamine Product Portfolio
  84. 8.14.5 Xinxiang Tianfeng Fine Chemical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Mesalamine Value Chain Analysis
  2. 9.1.1 Mesalamine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Mesalamine Sales Mode & Process
  6. 9.2 Mesalamine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Mesalamine Distributors
  9. 9.2.3 Mesalamine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst